SMN1 and proximal spinal muscular atrophy: Spinal muscular atrophy (SMA), an autosomal recessive disorder that affects approximately 1 in 6000–10,000 newborns worldwide due to homozygous deletion of SMN1 gene; it represents one of pediatric medicine’s most urgent therapeutic challenges.